Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000840193 | SCV000982113 | likely benign | not provided | 2018-03-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV001190218 | SCV001357661 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-10-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001455973 | SCV001659746 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-11-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001190218 | SCV002633695 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-07-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV001190218 | SCV003838351 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-03-08 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004002888 | SCV004814705 | likely benign | Marfan syndrome | 2023-12-07 | criteria provided, single submitter | clinical testing |